
Veterinary service providers Compassion First and National Veterinary Associates (NVA) have agreed to divest facilities in three locations to MedVet Associates, to settle Federal Trade Commission (FTC) charges that Compassion First’s proposed US$5 billion acquisition of NVA would violate federal antitrust law.
The FTC alleges that, as proposed, the acquisition would harm competition in three local geographic markets for various specialty and emergency veterinary services by eliminating close, head-to-head competition between Compassion First and NVA. In some markets, the acquisition would result in a merger to monopoly. The acquisition will increase the likelihood that Compassion First could unilaterally raise prices or decrease quality for specialty and emergency veterinary services, according to the complaint.
To remedy the proposed transaction’s anticompetitive effects, the order requires Compassion First and NVA to divest three clinics no later than 10 business days after the acquisition closes. The divestiture buyer, MedVet Associates, operates specialty and emergency veterinary clinics in other geographic markets and is well positioned to operate the three divested clinics.
Full Content: FTC
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas